Company Information
USD
-
- (-100%)
NASDAQ:NGM, NGM BIOPHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 23 April 2024 GMT-4
NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.
Address
333 Oyster Point Boulevard
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Ms. Siobhan Nolan Mangini
CFO/President
Ms. Irene Perlich
Chief Accounting Officer/Controller/Vice President
Dr. David V. Goeddel, PhD
Director
Dr. Roger M. Perlmutter,M.D.,PhD
Director
Mr. William J. Rieflin
Chairman of the Board/Director
Dr. Hsiao Dee Lieu, M.D.
Chief Medical Officer/Senior VP
Ms. Valerie L. Pierce
Chief Compliance Officer/General Counsel/Secretary/Senior VP
Ms. Suzanne Sawochka Hooper
Director
Ms. Shelly D. Guyer
Director
Dr. Carole Ho, M.D.
Director
Dr. David J. Woodhouse, PhD
CEO/Director
Ownership
Institution Holdings
Column Group LLC
18,136,735 (21.730%)
BlackRock Inc
3,178,165 (3.808%)
Vanguard Group Inc
2,770,574 (3.320%)
EcoR1 Capital, LLC
2,385,873 (2.859%)
BlackRock Fund Advisors
1,643,161 (1.969%)
StepStone Group LLC
1,573,357 (1.885%)
Acadian Asset Management LLC
1,339,331 (1.605%)
Vanguard Investments Australia Ltd
1,269,403 (1.521%)
Millennium Management LLC
1,262,395 (1.513%)
Euclidean Capital LLC
992,168 (1.189%)
Individual Holdings
Dr. David V. Goeddel, PhD
134,180 (0.162%)
Dr. David J. Woodhouse, PhD
131,822 (0.159%)
Ms. Siobhan Nolan Mangini
76,000 (0.093%)
Ms. Valerie L. Pierce
55,374 (0.067%)
Dr. Hsiao Dee Lieu, M.D.
54,254 (0.066%)
Ms. Irene Perlich
8,975 (0.011%)
Ms. Suzanne Sawochka Hooper
7,000 (0.011%)
Funds Holdings
iShares Russell 2000 ETF
1,109,204 (1.329%)
iShares Russell 2000 Value ETF
419,366 (0.502%)
State Street Russell Small/Mid Cap®
254,939 (0.305%)
Vanguard Health Care Index Fund
152,694 (0.183%)
Vanguard Russell 2000 Index Fund
145,999 (0.175%)
Russell 2000 Index Non-Lendable Fund E
112,098 (0.134%)
BlackRock - Extended Mkt Fund CF
91,083 (0.109%)
NT Russell 2000 Value Index Equity Strat
84,653 (0.101%)
NT R2000 Value Index Fund - L
84,653 (0.101%)
BlackRock Extended Equity Market
78,340 (0.094%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
